Zevra Therapeutics, Inc
Financing
Shares on issue
59.5M
From 42.0M in June 2024
a raise that quarter, at its price
Newest
$350.0M
S-3 of 2024-06-04. 1 prospectus supplement filed under it since.
$75.0M
Citizens JMP Securities, agreement of 2024-07-12. No at-the-market sales on file.
Warrants
2.53M
Warrants of every class.
Cash
$221.6M
Operating cash flow was positive, so the cash is not running down.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2024-08-09 | Public offering | 9,230,770 | $6.50 | $60.0M | 424B5 ↗ |